Ultralife Corporation
ULBI
$7.44
$0.223.05%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -1.27% | -6.50% | 10.56% | 21.51% | 12.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.27% | -6.50% | 10.56% | 21.51% | 12.98% |
| Cost of Revenue | -7.80% | -1.60% | 9.54% | 24.95% | 17.63% |
| Gross Profit | 19.52% | -21.05% | 13.75% | 10.79% | 0.33% |
| SG&A Expenses | -5.69% | -3.45% | 15.57% | 22.35% | 18.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.13% | -0.60% | 10.79% | 25.18% | 17.70% |
| Operating Income | 67.35% | -82.69% | 6.89% | -146.91% | -34.08% |
| Income Before Tax | 168.28% | -127.11% | -2,161.82% | -596.03% | -71.06% |
| Income Tax Expenses | 92.59% | -133.86% | -1,150.76% | -781.08% | -71.51% |
| Earnings from Continuing Operations | 189.43% | -125.07% | -3,298.71% | -546.95% | -70.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 177.78% | 242.86% | 179.49% | 228.57% | 137.50% |
| Net Income | 189.31% | -124.18% | -3,925.77% | -572.87% | -70.39% |
| EBIT | 67.35% | -82.69% | 6.89% | -146.91% | -34.08% |
| EBITDA | 41.13% | -60.99% | 8.13% | -39.49% | -18.91% |
| EPS Basic | 189.20% | -124.17% | -3,909.40% | -572.90% | -70.54% |
| Normalized Basic EPS | 168.68% | -91.94% | 107.93% | -295.33% | -61.98% |
| EPS Diluted | 200.00% | -127.27% | -4,304.72% | -572.90% | -72.10% |
| Normalized Diluted EPS | 168.26% | -91.92% | 109.38% | -298.10% | -61.46% |
| Average Basic Shares Outstanding | 0.14% | 0.14% | 0.15% | 0.13% | 0.40% |
| Average Diluted Shares Outstanding | 0.35% | -0.14% | -0.64% | -1.35% | -1.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |